MedTrace Logo

Remote Monitoring Use In Cases Of Suspected COVID-19 (Coronavirus)

NCT04337489 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 15

Last updated 2024-10-08

Study results available
· View outcomes & findings →

Summary

The study aims to see if participant deterioration due to suspected coronavirus in a designated location (e.g. hotel) can be identified sooner by wearing the sensor. If sick patients can be identified early, participants are more likely to have better outcomes; the study believes that the sensor can help us do this. The sensor measures heart rate, respiratory rate and temperature every 2 minutes and this can be reviewed by the clinical team looking after the participants.

Conditions

  • Coronavirus

Interventions

DEVICE

SensiumVitals wearable sensor

A waterproof, light, wearable sensor measuring vital signs (heart rate, respiratory rate, temperature) continuously.

Sponsors & Collaborators

  • CW+ Charity

    collaborator OTHER

  • Imperial College London

    lead OTHER

Principal Investigators

  • Ara Darzi, Prof · Institute of Global Health Innovation

Eligibility

Min Age
18 Years
Max Age
95 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-07-28
Primary Completion
2021-03-26
Completion
2021-03-26
FDA Device
Yes

Countries

  • United Kingdom

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04337489 on ClinicalTrials.gov